お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はがん治療におけるゲノミクス市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはがん治療におけるゲノミクスの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のがん治療におけるゲノミクス市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはがん治療におけるゲノミクスのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にがん治療におけるゲノミクス市場を分類しています。本研究に含まれる主な企業は：Illumina、Thermo Fisher scientific、Agilent、Roche、Cancer Genetics、Beckman Coulter、Bio-Rad、Danaher、Sigma Aldrich、Pacific Biosciences、Quest Diagnostics、Luminex、Oxford Gene Technology、PerkinElmer、Qiagen、GE Healthcare

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Instruments
    Consumables
    Services

用途別の市場セグメント：
    Diagnostics
    Personalized Medicine
    Drug Discovery
    Development
    Research

本レポートの詳細内容
世界のがん治療におけるゲノミクス市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、がん治療におけるゲノミクスタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のがん治療におけるゲノミクス収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のがん治療におけるゲノミクス市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、がん治療におけるゲノミクス市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

がん治療におけるゲノミクスのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：がん治療におけるゲノミクスのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：がん治療におけるゲノミクスの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章がん治療におけるゲノミクス企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：がん治療におけるゲノミクスの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：がん治療におけるゲノミクスの主要企業の概要を提供し、製品の説明と仕様、がん治療におけるゲノミクスの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Genomics In Cancer Care Market
The global Genomics In Cancer Care market is projected to grow from US$ 32040 million in 2024 to US$ 70990 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.2% during the forecast period.
The US & Canada market for Genomics In Cancer Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Genomics In Cancer Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Genomics In Cancer Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Genomics In Cancer Care include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Genomics In Cancer Care is widely used in various fields, such as Diagnostics, Personalized Medicine, Drug Discovery and Development, etc. Diagnostics provides greatest supports to the Genomics In Cancer Care industry development. In 2023, global % revenue of Genomics In Cancer Care went into Diagnostics filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Genomics In Cancer Care market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Genomics In Cancer Care, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genomics In Cancer Care, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genomics In Cancer Care revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Genomics In Cancer Care market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Genomics In Cancer Care revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc.

Market Segmentation
By Company
    Illumina
    Thermo Fisher scientific
    Agilent
    Roche
    Cancer Genetics
    Beckman Coulter
    Bio-Rad
    Danaher
    Sigma Aldrich
    Pacific Biosciences
    Quest Diagnostics
    Luminex
    Oxford Gene Technology
    PerkinElmer
    Qiagen
    GE Healthcare

Segment by Type
    Instruments
    Consumables
    Services

Segment by Application
    Diagnostics
    Personalized Medicine
    Drug Discovery
    Development
    Research

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Genomics In Cancer Care in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomics In Cancer Care companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genomics In Cancer Care revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Instruments
    Table 3. Key Players of Consumables
    Table 4. Key Players of Services
    Table 5. Global Genomics In Cancer Care Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Genomics In Cancer Care Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Genomics In Cancer Care Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Genomics In Cancer Care Market Share by Region (2019-2024)
    Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Genomics In Cancer Care Market Share by Region (2025-2030)
    Table 11. Genomics In Cancer Care Market Trends
    Table 12. Genomics In Cancer Care Market Drivers
    Table 13. Genomics In Cancer Care Market Challenges
    Table 14. Genomics In Cancer Care Market Restraints
    Table 15. Global Genomics In Cancer Care Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Genomics In Cancer Care Revenue Share by Players (2019-2024)
    Table 17. Global Top Genomics In Cancer Care by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2023)
    Table 18. Global Genomics In Cancer Care Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Genomics In Cancer Care, Headquarters and Area Served
    Table 21. Global Key Players of Genomics In Cancer Care, Product and Application
    Table 22. Global Key Players of Genomics In Cancer Care, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Genomics In Cancer Care Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2019-2024)
    Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2025-2030)
    Table 28. Global Genomics In Cancer Care Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Genomics In Cancer Care Revenue Share by Application (2019-2024)
    Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Genomics In Cancer Care Revenue Share by Application (2025-2030)
    Table 32. North America Genomics In Cancer Care Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Genomics In Cancer Care Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Genomics In Cancer Care Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Genomics In Cancer Care Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Genomics In Cancer Care Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Genomics In Cancer Care Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Genomics In Cancer Care Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Genomics In Cancer Care Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Genomics In Cancer Care Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Genomics In Cancer Care Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Genomics In Cancer Care Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Genomics In Cancer Care Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Genomics In Cancer Care Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Genomics In Cancer Care Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Genomics In Cancer Care Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Genomics In Cancer Care Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Genomics In Cancer Care Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Genomics In Cancer Care Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Genomics In Cancer Care Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Genomics In Cancer Care Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Genomics In Cancer Care Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Genomics In Cancer Care Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Genomics In Cancer Care Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Illumina Company Details
    Table 65. Illumina Business Overview
    Table 66. Illumina Genomics In Cancer Care Product
    Table 67. Illumina Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 68. Illumina Recent Developments
    Table 69. Thermo Fisher scientific Company Details
    Table 70. Thermo Fisher scientific Business Overview
    Table 71. Thermo Fisher scientific Genomics In Cancer Care Product
    Table 72. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 73. Thermo Fisher scientific Recent Developments
    Table 74. Agilent Company Details
    Table 75. Agilent Business Overview
    Table 76. Agilent Genomics In Cancer Care Product
    Table 77. Agilent Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 78. Agilent Recent Developments
    Table 79. Roche Company Details
    Table 80. Roche Business Overview
    Table 81. Roche Genomics In Cancer Care Product
    Table 82. Roche Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 83. Roche Recent Developments
    Table 84. Cancer Genetics Company Details
    Table 85. Cancer Genetics Business Overview
    Table 86. Cancer Genetics Genomics In Cancer Care Product
    Table 87. Cancer Genetics Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 88. Cancer Genetics Recent Developments
    Table 89. Beckman Coulter Company Details
    Table 90. Beckman Coulter Business Overview
    Table 91. Beckman Coulter Genomics In Cancer Care Product
    Table 92. Beckman Coulter Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 93. Beckman Coulter Recent Developments
    Table 94. Bio-Rad Company Details
    Table 95. Bio-Rad Business Overview
    Table 96. Bio-Rad Genomics In Cancer Care Product
    Table 97. Bio-Rad Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 98. Bio-Rad Recent Developments
    Table 99. Danaher Company Details
    Table 100. Danaher Business Overview
    Table 101. Danaher Genomics In Cancer Care Product
    Table 102. Danaher Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 103. Danaher Recent Developments
    Table 104. Sigma Aldrich Company Details
    Table 105. Sigma Aldrich Business Overview
    Table 106. Sigma Aldrich Genomics In Cancer Care Product
    Table 107. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 108. Sigma Aldrich Recent Developments
    Table 109. Pacific Biosciences Company Details
    Table 110. Pacific Biosciences Business Overview
    Table 111. Pacific Biosciences Genomics In Cancer Care Product
    Table 112. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 113. Pacific Biosciences Recent Developments
    Table 114. Quest Diagnostics Company Details
    Table 115. Quest Diagnostics Business Overview
    Table 116. Quest Diagnostics Genomics In Cancer Care Product
    Table 117. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 118. Quest Diagnostics Recent Developments
    Table 119. Luminex Company Details
    Table 120. Luminex Business Overview
    Table 121. Luminex Genomics In Cancer Care Product
    Table 122. Luminex Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 123. Luminex Recent Developments
    Table 124. Oxford Gene Technology Company Details
    Table 125. Oxford Gene Technology Business Overview
    Table 126. Oxford Gene Technology Genomics In Cancer Care Product
    Table 127. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 128. Oxford Gene Technology Recent Developments
    Table 129. PerkinElmer Company Details
    Table 130. PerkinElmer Business Overview
    Table 131. PerkinElmer Genomics In Cancer Care Product
    Table 132. PerkinElmer Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 133. PerkinElmer Recent Developments
    Table 134. Qiagen Company Details
    Table 135. Qiagen Business Overview
    Table 136. Qiagen Genomics In Cancer Care Product
    Table 137. Qiagen Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 138. Qiagen Recent Developments
    Table 139. GE Healthcare Company Details
    Table 140. GE Healthcare Business Overview
    Table 141. GE Healthcare Genomics In Cancer Care Product
    Table 142. GE Healthcare Revenue in Genomics In Cancer Care Business (2019-2024) & (US$ Million)
    Table 143. GE Healthcare Recent Developments
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomics In Cancer Care Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Genomics In Cancer Care Market Share by Type: 2023 VS 2030
    Figure 3. Instruments Features
    Figure 4. Consumables Features
    Figure 5. Services Features
    Figure 6. Global Genomics In Cancer Care Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Genomics In Cancer Care Market Share by Application: 2023 VS 2030
    Figure 8. Diagnostics Case Studies
    Figure 9. Personalized Medicine Case Studies
    Figure 10. Drug Discovery Case Studies
    Figure 11. Development Case Studies
    Figure 12. Research Case Studies
    Figure 13. Genomics In Cancer Care Report Years Considered
    Figure 14. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Genomics In Cancer Care Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Genomics In Cancer Care Market Share by Region: 2023 VS 2030
    Figure 17. Global Genomics In Cancer Care Market Share by Players in 2023
    Figure 18. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2023
    Figure 20. North America Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Genomics In Cancer Care Market Share by Type (2019-2030)
    Figure 22. North America Genomics In Cancer Care Market Share by Application (2019-2030)
    Figure 23. North America Genomics In Cancer Care Market Share by Country (2019-2030)
    Figure 24. United States Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Genomics In Cancer Care Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Genomics In Cancer Care Market Share by Type (2019-2030)
    Figure 28. Europe Genomics In Cancer Care Market Share by Application (2019-2030)
    Figure 29. Europe Genomics In Cancer Care Market Share by Country (2019-2030)
    Figure 30. Germany Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Genomics In Cancer Care Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Genomics In Cancer Care Market Share by Type (2019-2030)
    Figure 38. China Genomics In Cancer Care Market Share by Application (2019-2030)
    Figure 39. Asia Genomics In Cancer Care Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Genomics In Cancer Care Market Share by Type (2019-2030)
    Figure 41. Asia Genomics In Cancer Care Market Share by Application (2019-2030)
    Figure 42. Asia Genomics In Cancer Care Market Share by Region (2019-2030)
    Figure 43. Japan Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Country (2019-2030)
    Figure 53. Brazil Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Genomics In Cancer Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 60. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 61. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 62. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 63. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 64. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 65. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 66. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 67. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 68. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 69. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 70. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 71. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 72. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 73. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 74. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2019-2024)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed